BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 224 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q2 2021. The put-call ratio across all filers is 1.19 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $5,174,000 | -41.0% | 53,300 | -58.5% | 0.23% | -36.5% |
| Q1 2021 | $8,769,000 | +23.1% | 128,300 | +54.4% | 0.36% | +18.7% |
| Q4 2020 | $7,123,000 | +29.5% | 83,100 | -1.8% | 0.30% | +11.7% |
| Q3 2020 | $5,500,000 | -11.1% | 84,600 | 0.0% | 0.27% | -31.6% |
| Q2 2020 | $6,185,000 | +236.0% | 84,600 | +56.4% | 0.40% | +224.4% |
| Q1 2020 | $1,841,000 | -5.8% | 54,100 | +50.7% | 0.12% | -2.4% |
| Q4 2019 | $1,954,000 | +30.4% | 35,900 | 0.0% | 0.13% | -51.0% |
| Q3 2019 | $1,498,000 | – | 35,900 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 1,111,111 | $107,867,000 | 52.60% |
| Knoll Capital Management, LLC | 856,844 | $83,182,000 | 43.44% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,082,555 | $202,174,000 | 27.86% |
| ARS Investment Partners, LLC | 558,286 | $54,198,000 | 5.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $17,113,000 | 4.52% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 401,006 | $38,930,000 | 4.51% |
| Eventide Asset Management | 1,990,797 | $193,267,000 | 2.60% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 56,626 | $5,497,000 | 2.45% |
| Avidity Partners Management LP | 882,500 | $85,673,000 | 2.32% |
| Nicholas Investment Partners, LP | 363,708 | $35,309,000 | 2.22% |